Accession PRJCA013746
Title EML4-ALK fusions drive lung adeno-to-squamous transdifferentiation through phase separation-mediated JAK-STAT activation
Relevance Medical
Data types Transcriptome or Gene expression
Single cell sequencing
Organisms Homo sapiens
Description Human lung adenosquamous cell carcinoma (LUAS), containing both adenomatous and squamous pathologies, exhibit strong cancer plasticity. We find that ALK-rearrangement is detectable in 5.1-7.5% human LUAS and transgenic expression of EML4-ALK fusion drives lung adenocarcinoma (LUAD) formation initially and squamous transformation at late stage. We identify club cells as the main cell-of-origin for squamous transformation. Through recapitulating such lineage transition in organoids system, we identify JAK-STAT signaling, activated by EML4-ALK phase separation, significantly promotes squamous transformation. Integrative study with scRNA-seq and immunostaining identify a plastic cell subpopulation in ALK-rearranged human LUAD showing squamous biomarker expression. Moreover, those relapsed ALK-rearranged LUAD show notable upregulation of squamous biomarkers. Consistently, mouse squamous tumors or LUAD with squamous signature display certain resistance to ALK inhibitor, which can be overcome by combined JAK1/2 inhibitor treatment. This study uncovers strong plasticity of ALK-rearranged tumors in orchestrating phenotypic transition and drug resistance and proposes a potentially effective therapeutic strategy.
Sample scope Multispecies
Release date 2022-12-08
Publication
PubMed ID Article title Journal name DOI Year
38284990 EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation Journal of Experimental Medicine 10.1084/jem.20232028 2024
Grants
Agency program Grant ID Grant title
No funding support
Submitter Shijie Tang (tangshijie6@sibcb.ac.cn)
Organization Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
Submission date 2022-12-08

Project Data

Resource name Description